School of Medicine
Showing 1-50 of 88 Results
-
Uri Ladabaum
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsGastrointestinal cancer prevention and risk management. Risk stratification. Cost-effectiveness analysis. Health services research.
-
Richard Lafayette
Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsWe are continuing to grow a glomerulonephritis cohort study, including immunologic characterization. We have completed interventional studies of preeclampsia exploring the nitric oxide, endothelin system and effects on glomerular function and morphometry. We continue to recruit patients for treatment and observational studies of glomerular disease, including FSGS, membranous and particularly IgA nephropathy. We also are actively studying renal disease in systemic amyloidosis.
-
Fadi George Lakkis
Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsI study how the immune system rejects transplanted organs, with the goal of improving long-term transplant outcomes. A related area of research in my laboratory is the relationship between maternal-fetal immune interactions and reproductive success.
https://pubmed.ncbi.nlm.nih.gov/?term=Lakkis+FG%5BAuthor%5D&sort=date -
Rayhan A. Lal, MD
Assistant Professor of Medicine (Endocrinology) and of Pediatrics (Endocrinology)
BioI grew up in the east bay area and have had type 1 diabetes for 30+ years. I studied electrical engineering and computer science at U.C. Berkeley (Go Bears!) with the hope of applying my knowledge to diabetes technology. The significance of clinical practice became clear to me after my siblings also developed diabetes. I am devoting my life to advancing the care of diabetes in people of all ages.
-
Vinh Lam
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Vinh Lam is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population health. He earned his MD from the David Geffen School of Medicine at UCLA and chose to stay in Los Angeles to complete his family medicine residency training at UCLA. During his training, Dr. Lam developed a strong interest in teaching and medical education through his involvement with resident education and the graduate medical education committee. He also spent 1 year as a resident informaticist where he also became very interested in informatics, medical technology, and innovative solutions to improving patient health outcomes and decreasing physician burnout. Dr. Lam enjoys caring for patients of all ages from pediatrics to geriatrics, performing office-based procedures, and prioritizing preventative care.
Outside of medicine, Dr. Lam loves to travel with his family, dabbles in photography and videography, and enjoys attempting to recreate meals he has had while traveling with his wife. -
Curtis Langlotz
Senior Associate Vice Provost for Research, Professor of Radiology (Integrative Biomedical Imaging Informatics), of Medicine (BMIR), of Biomedical Data Science and Senior Fellow at the Stanford Institute for Human-Centered AI
Current Research and Scholarly InterestsMy laboratory develops machine learning methods to help physicians detect disease and eliminate diagnostic errors. My laboratory is developing neural network systems that detect and classify disease on medical images. We also develop natural language processing methods that use the narrative radiology report for contrastive learning and other multi-modal methods that improve the accuracy and capability of machine learning systems.
-
Benjamin Laniakea
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Benji Laniakea serves as the chief of the Stanford LGBTQ+ Adult Clinical Program, which offers comprehensive and tailored healthcare for the LGBTQ+ patient population for patients of all ages, sexualities, and gender identities. They also serve as the theme lead for the Sex, Gender, Sexuality, and Sexual Function curriculum at the Stanford School of Medicine for which they received the Arthur L. Bloomfield Award.
-
Tobias Lanz
Assistant Professor of Medicine (Immunology and Rheumatology)
BioTobias Lanz, MD is an Assistant Professor at the Institute for Immunity, Transplantation, and Infection and the Division of Immunology and Rheumatology at Stanford. His research focuses on B cell biology in neuroimmunological diseases and rheumatic diseases with neurological manifestations. He uses high-throughput screening technologies, and methods from structural and cell biology to identify new autoantigens and to understand how certain self-reactive B cells escape tolerance mechanisms. He is particularly interested in molecular mechanisms that explain the association between Epstein Barr Virus (EBV) and autoimmunity.
Tobias went to medical school at the Eberhard Karls University in Tübingen, Germany and at the University College of London. He wrote his MD thesis at Dr. Michael Platten's laboratory at the Hertie Institute for Clinical Brain Research in Tübingen, Germany before joining Dr. Lawrence Steinman’s neuroimmunological laboratory at Stanford as a research scholar. After medical school he pursued his scientific and clinical training at the German Cancer Research Center (DKFZ) and the Department of Neurology at the University Hospital in Heidelberg, Germany. In 2015 he joined Dr. William Robinson’s lab at Stanford, where he investigated environmental triggers of autoimmunity, including viruses and milk consumption. In his most recent work, he characterized the B cell repertoire in the spinal fluid of patients with multiple sclerosis (MS) and identified molecular mimicry between EBV EBNA1 and the glial cellular adhesion molecule GlialCAM as a driver of neuroinflammation (Lanz et al., Nature, 2022). His long term objective is to leverage these newly discovered mechanistic insights to develop next-generation biomarkers and therapeutics for autoimmune diseases. -
Alice A. Lee
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Lee's research focuses on the early detection of pancreatic cancer, including the investigation of risk factors for pancreatic cancer and biomarkers to detect early cancer.
-
Byron Lee
Professor of Medicine (Cardiovascular)
BioDr. Byron Lee is Professor of Medicine in the Division of Cardiovascular Medicine and Cardiac Electrophysiology Section. He has published over 150 peer reviewed articles and 10 book chapters. He has written two books to help students navigate the medical school admission process: Insider's Premed Guidebook and Insider's High School Premed Guidebook. His research team studies treatments to prevent sudden cardiac death, atrial fibrillation, and complications of cardiac device lead extraction. He has won numerous teaching awards for his work with medical students, residents, and fellows. He also serves as Chief of Cardiac Electrophysiology at the Palo VA Medical Center and Head Cardiologist for University of California Athletics.
-
David Lee, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests1. Novel treatments and devices for the treatment of valvular disease
2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
3. Novel approaches to coronary revascularization
4. Closure devices for atrial septal defects and patent foramen ovale
5. Novel treatments for hypertension -
Jennifer Lee
Professor of Medicine (Endocrinology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsI am a healthcare lead and physician scientist for innovation, R&D, and advanced analytics, and oversee these aspects at VA Palo Alto/VHA, within Stanford-VA relationship. The VA has the US's largest health care system and longest running EHR. I prioritize enabling multiple partners (industry, government, academia, foundations), to innovate/R&D in the VA health care system. We prioritize mentoring students from various Schools to become future leaders in R&D, innovation, and healthcare.
-
Julie Jung Hyun Lee
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Julie J. Lee is a board-certified internal medicine physician, epidemiologist, and clinical informaticist at Stanford University. She works at the forefront of responsible technology and artificial intelligence (AI) integration in healthcare—spanning research, operations, and real-world clinical use. With degrees in Psychology from Columbia University and Epidemiology from Yale University, Dr. Lee brings a unique perspective as an end-user clinician, public health researcher, and systems thinker with deep technical fluency.
At the Stanford Division of Primary Care and Population Health, she serves as Clinical Assistant Professor and Health Equity Informaticist, leading data-informed strategies to close care gaps and implement technology that works in real clinical environments—particularly in primary care settings where systemic challenges around access, coordination, and equity are most visible. Her informatics work encompasses implementation research, governance and operations of clinical decision support (CDS), integration of Prescription Drug Monitoring Programs (PDMPs), deployment of continuous glucose monitors (CGMs) in inpatient settings, and human factors research to improve health IT usability and physician-patient communication.
Dr. Lee’s expertise spans interoperability, EHR physician-builder capabilities, and human-centered design—applying design thinking, data science, and implementation science to drive equitable, clinically grounded innovations. Her focus on clinical feasibility ensures AI tools and digital health interventions are scalable, operationally feasible, and aligned with the real needs of patients and frontline care teams. She advises industry and innovators on designing health technologies that bridge the gap between innovation and implementation.
Health equity is Dr. Lee’s north star, guiding her work in both academic and community settings. Her decade of research spans cardiometabolic health, diabetes, applied AI, and patient safety, with a consistent focus on underserved populations. She has led projects on language and acculturation in Latino communities, translated liver disease research into frontline care in East Los Angeles, and contributed to foundational studies on sex-specific cardiovascular risk factors in women and transgender populations. She is currently focused on advancing precision health for Asian and Native Hawaiian and Pacific Islander (NHPI) communities, particularly in the realm of obesity medicine.
Dr. Lee is widely published in journals such as Diabetes Care, JAMA Network Open, NPJ Digital Medicine, Applied Clinical Informatics, Journal of the American Heart Association, and Menopause. Her informatics philosophy centers on translating research into practice—bringing high-quality evidence directly to clinicians in ways that are actionable, equitable, and embedded into the EHR workflow. -
Seolhyun Lee, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Lee is a nephrologist and Clinical Assistant Professor in the Nephrology Division of the Stanford Department of Medicine.
He delivers expert, compassionate kidney care personalized to each patient he serves. Dr. Lee is committed to improving both the health and quality of life of his patients.
His work scholarship has appeared in the Journal of the American Society of Nephrology, Kidney Week, and Blood Purification.
Dr. Lee has received honors and awards including the prestigious Ben J. Lipps Research Fellowship from the American Society of Nephrology. The program funds original research projects by nephrology fellows. -
Mary Leonard
Arline and Pete Harman Professor, Professor of Pediatrics (Nephrology), of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.
-
John Leppert
Professor of Urology and, by courtesy, of Nephrology
Current Research and Scholarly InterestsOur research aims to improve the global quality of care for patients with Urologic Cancer with a particular focus on kidney cancer. We are investigating novel proteomic platforms and assays to diagnose kidney cancer and predict response to therapy. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are applying epidemiology, bioinformatics, and health services methods to urologic conditions.
-
Krystle Man-Chin Leung, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Leung is a board-certified, fellowship-trained pulmonologist, intensivist, and sleep specialist with Stanford Health Care and a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine.
Dr. Leung specializes in pulmonology, critical care, and sleep medicine, focusing on sleep-disordered breathing, chronic lung disease, and ventilator management in the intensive care unit (ICU) and at home. Dr. Leung also focuses on patients with chronic obstructive pulmonary disease, chronic respiratory failure, neuromuscular respiratory weakness, obesity hypoventilation syndrome, restrictive lung disease, and sleep apnea. She provides compassionate, patient-centered care, emphasizing shared decision-making and aligning medical treatments with patients’ values and preferences.
Dr. Leung’s research interests include optimizing care for patients who require home ventilation and those who have or have survived critical illnesses. She has prior research experience in prolonged mechanical ventilation, thoracic imaging, and asthma.
Dr. Leung has published her work in numerous peer-reviewed journals and presented at national conferences.
Dr. Leung is a member of the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. -
Lawrence Leung
Maureen Lyles D'Ambrogio Professor in the School of Medicine
Current Research and Scholarly InterestsOur long term interest is to have a better understanding of the natural antithrombotic pathways and the pathophysiology of vascular thrombosis. We have focused on thrombin, the key enzyme in the blood clotting cascade.Our goal is to develop new antithrombotic agents and devise new diagnostic tests for vascular thrombotic disorders.
-
Eleanor Levin
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular Value Based Care, Cardio-Obstetrics, Dyslipidemia Treatment
-
Deborah J Levine, MD, FCCP, FAST
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Deborah Jo Levine is a board-certified pulmonologist and lung transplantation and pulmonary hypertension specialist. She is a clinical professor of medicine in the Department of Pulmonary, Allergy, and Critical Care Medicine. Dr. Levine also serves as director of lung transplant outreach for Stanford Health Care.
Dr. Levine is internationally recognized for her work in lung transplantation and pulmonary hypertension (PH). She has been instrumental in developing international guidelines for defining, diagnosing, and managing antibody-mediated rejection (AMR) after lung transplantation. She has served as chair of pulmonary AMR guidelines for the International Society of Heart and Lung Transplantation.
Dr. Levine’s research interests include lung allograft monitoring and risk assessment. Her research has also included monitoring lung allograft health using donor-derived cell-free DNA (dd-cfDNA)—a technique pioneered at Stanford Medicine. She has received National Institutes of Health (NIH) funding as a clinical investigator. Dr. Levine is a co-chair of the ALAMO (AlloSure Lung Assessment and Metagenomics Outcomes) Study national registry. She has been involved in many clinical trials in lung transplantation and pulmonary hypertension.
As a respected educator and researcher, Dr. Levine has led and contributed to dozens of abstracts, presentations, and peer-reviewed articles. She has also written several books and book chapters on pulmonary hypertension, interstitial lung disease, pulmonary vascular disorders, and lung transplantation.
Dr. Levine is editor-in-chief for Advances in Pulmonary Hypertension, the quarterly journal of the Pulmonary Hypertension Association. She is an editorial board member of The Journal of Heart and Lung Transplantation and an ad hoc reviewer for several other industry journals. Dr. Levine also serves as a grant reviewer and section study reviewer for the American College of Chest Physicians and the American Society of Transplantation.
Dr . Levine is a fellow of the American College of Chest Physicians and the American Society of Transplantation. She is also the chair of the Diffuse Lung Disease and Lung Transplant Network and the incoming vice chair of the Council of Networks for the American College of Chest Physicians (CHEST). -
Joseph Levitt, MD, MS
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsMy research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).
-
Lee Levitt
Professor of Medicine (Hematology) at the Santa Clara Valley Medical Center, Emeritus
Current Research and Scholarly InterestsLow molecular-weight heparins Clinical trials with anti-thrombotics Clinical trials in patients with leukemia, breast cancer and myeloma Medical education.
-
Ronald Levy, MD
Robert K. and Helen K. Summy Professor in the School of Medicine
Current Research and Scholarly InterestsClinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.
-
Eldrin F. Lewis, MD, MPH
Simon H. Stertzer, MD, Professor
BioDr. Lewis is a board-certified, fellowship-trained specialist in cardiovascular medicine. He is the chief of the Division of Cardiovascular Medicine and a professor of cardiovascular medicine.
Dr. Lewis is an esteemed clinician-scientist who specializes in the care of patients with advanced heart failure. He is an internationally recognized expert on heart failure, heart transplant, and quality of life for heart failure patients. He cares deeply about his patients as well as his colleagues, the hospital, and the School of Medicine. Dr. Lewis is committed to diversity and inclusion, as well as expanding Stanford clinical research initiatives.
A fundamental principle of Dr. Lewis’ practice is his belief that “there is more to life than death,” that cardiovascular care should go beyond helping patients survive to also helping them enjoy the best possible quality of life.
Dr. Lewis has deep expertise in conducting clinical trials examining diagnostic and therapeutic approaches to heart failure. He has done innovative work to create systems for incorporating quality of life measures for cardiovascular patients into electronic health records. This research has received support from the National Heart, Lung and Blood Institute and the National Institutes of Health.
Much of his quality of life research has focused on patient-reported outcomes. Dr. Lewis emphasizes the importance of looking at how a disease, whether chronic or acute, impacts people’s ability to function and perform their activities of daily living. Strategies to improve patients’ well-being focus not only on their physical symptoms but also on depression, anxiety, exercise capacity, and ability to function in daily living.
Dr. Lewis’ commitment to expanding clinical research initiatives will give patients more opportunities to participate in the clinical trials and access the latest care strategies that can translate into better outcomes. The goal is early access to the most advanced technology, pharmacology, and device therapy that can change outcomes for the better. He also envisions forming closer partnerships with community cardiologists and capitalizing further on Stanford’s proximity to and unique relationships with the digital technology leaders of Silicon Valley to enhance the use of digital technology for monitoring patients, optimizing treatment, and tracking outcomes.
He has authored nearly 200 articles published in peer-reviewed journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, JAMA Internal Medicine, and many more. He is also on multiple editorial boards for cardiovascular journals and was an associate editor for Circulation–Heart Failure. In addition, he is an author of professional society clinical practice guidelines and scientific statements from both the American Heart Association (AHA) and the Food and Drug Administration.
Dr. Lewis’ honors for clinical care, scholarship, and research include the Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine. He also was one of the first recipients of the Minority Faculty Development Award, which recognizes the research potential of young physicians. Dr. Lewis has received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure.
He is a fellow of the American College of Cardiology and the National American Heart Association (AHA) Research Committee. In addition, Dr. Lewis was as a member of the AHA Founders Affiliate Board of Directors, chair of the Council on Clinical Cardiology, and research chair of the Association of Black Cardiologists. He also serves on scientific committees to review grants for the AHA and on the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials. -
Andrew A. Li, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Li is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. He is a clinical assistant professor in the Department of Medicine, Division of Gastroenterology and Hepatology at Stanford University School of Medicine.
A therapeutic endoscopy specialist, Dr. Li received fellowship training in gastroenterology, advanced endoscopy, and endoscopic surgery at Stanford University School of Medicine. He is board certified in internal medicine and gastroenterology.
Dr. Li specializes in advanced endoscopic procedures. His areas of expertise include endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), enteroscopy, endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). He also specializes in esophageal peroral endoscopic myotomy (POEM), gastric peroral endoscopic myotomy (GPOEM), and Zenker’s diverticulum peroral endoscopic myotomy (ZPOEM).
In addition, he treats gastrointestinal cancers, including gastric (stomach) cancer and colon cancer. He is dedicated to helping patients by integrating leading-edge research and innovations with compassionate, patient-centered clinical care.
Dr. Li’s research interests include gastric cancer, innovations in advanced endoscopy and endoscopic surgery, and the application of artificial intelligence (AI) and other computational techniques for prevention, diagnoses, and treatments.
Dr. Li has published articles in the World Journal of Gastrointestinal Endoscopy, Gastrointestinal Endoscopy, and Endoscopy International Open. He has presented at national and international conferences held in Las Vegas; Washington, D.C.; and Seoul, Korea. In his many presentations, he has covered topics such as the prevention of gastric cancer and prevention of post-ERCP pancreatitis.
Dr. Li is a member of the American Society for Gastrointestinal Endoscopy, American College of Gastroenterology, American Gastroenterological Association, and American College of Physicians. -
Daniel Yuhang Li
Instructor, Medicine - Cardiovascular Medicine
BioI am a physician scientist in the Division of Cardiology at Stanford. My clinical interest is at the intersection of inflammation, autoimmunity and cardiovascular disease in a field called 'Cardio-Rheumatology'. Patients with rheumatologic diseases typically have an elevated cardiovascular disease risk profile along with an insidious onset. Moreover, with the ever-expanding biologic drug formulary for patients, it is important for us to characterize the cardiovascular effects of these medications. In my research, I believe that understanding how inflammatory and autoimmune mechanisms modify coronary artery disease can help us develop a novel perspective towards treating atherosclerosis beyond lipid lowering. My research goal is to advance novel therapeutics for atherosclerosis by leveraging my expertise in genetics, computational biology, and experience with diverse model organism perturbation models. My strategy employs a ‘systems’ approach, starting with human population variations at the genetic level and integrating findings across RNA, protein, and model organism studies. This comprehensive synthesis aims to grasp the overarching biological narrative, thereby facilitating the development of translational therapies that transform concepts from bench to bedside.
-
Ron Li
Clinical Associate Professor, Medicine
BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is also the founding Medical Director for Stanford Health Care at Home and the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.
Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is the Associate Program Director for the Stanford Clinical Informatics Fellowship. -
April Shichu Liang
Clinical Assistant Professor, Medicine
BioApril S. Liang, M.D., is a Board-Certified internist and Clinical Informaticist. She serves as Clinical Assistant Professor in the Stanford Division of Hospital Medicine as well as Medical Informatics Director. Dr. Liang holds a B.S.E. in Computer Science from Princeton University and an M.D. from UCSF School of Medicine. She completed Internal Medicine residency at UCSF and Clinical Informatics fellowship at Stanford. Dr. Liang’s informatics interests include the implementation of AI tools in healthcare and data-driven quality improvement. Her past work includes the integrating a machine learning-driven clinical decision support tool in the EHR targeting lab overutilization and measuring the impact of ambient AI scribes on clinician documentation time.
-
Charles Liao
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsEducational Curriculum: Working with Professional Interpreters
-
Ronglih Liao
Douglass M. and Nola Leishman Professor of Cardiovascular Disease
BioDr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.
In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.
Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally. -
Michaela Liedtke
CKD Family Professor
Current Research and Scholarly Interests1) Design of phase I/II trials for the treatment of Multiple Myeloma and Amyloidosis
2) Conduct of clinical trials to improve the treatment of patients with acute lymphoblastic leukemia (ALL)
3) Outcomes research using clinical databases for patients with Multiple Myeloma and Amyloidosis -
Michael Lim, M.D.
Stanford Medicine Endowed Chair of the Department of Neurosurgery, Professor of Neurosurgery and, by courtesy, of Radiation Oncology, of Medicine, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences
BioDr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia.
Dr. Lim’s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.
As a mentor, he has garnered numerous teaching awards, including being honored as an outstanding teacher by Johns Hopkins University School of Medicine. He is actively involved in shaping education for neurosurgery and oncology across the United States and around the world. He is the recipient of the prestigious 2023 Abhijit Guha Award in Neuro-Oncology.
Dr. Lim’s research interests focus on harnessing the immune system to fight cancer. His laboratory focuses on understanding mechanisms of immune evasion by cancer cells. He has successfully translated his findings from the laboratory to the clinics and has conducted and led several large national immunotherapy clinical trials for brain tumors.
Dr. Lim’s bibliography contains well over 300 articles on topics such as immunotherapy for glioblastoma, long-term survival of glioma patients treated with stereotactic radiation, and treatment of neuropathic pain. His work has appeared in Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, Nature Immunology, and many more publications. He also has written 20 book chapters and monographs.
Dr. Lim is a world leader in immunotherapy for brain tumors. In addition to being invited world-wide to give lectures and seminars, he has given platform presentations on the topics of immunotherapy for brain tumors, neurosurgical techniques and management of brain tumors at the American Society of Clinical Oncologists, American Academy of Neurological Surgeons, Radiological Society of North America, Annual Symposium on Brain and Spine Metastases, Congress of Neurological Surgeons, and other meetings. In addition, he has served as platform chairman of the CNS session at the American Society for Clinical Oncology conference.
Dr. Lim is a member of the American Society for Clinical Oncology, Congress of Neurological Surgeons, American Association of Neurological Surgeons, and Society for Neuro-Oncology. Dr. Lim served as the program co-chair of the Society for Neuro-Oncology and CNS section of the American Society for Clinical Oncology. He also served on many executive committees, including the Executive Committee for the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.
Trigeminal neuralgia treatment: https://www.youtube.com/watch?v=-n8nvwkwZik
Trigeminal neuralgia patient stories: https://www.youtube.com/watch?v=kClePRPYlQs&t=1s
